Edition:
United States

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

15.70USD
3:59pm EST
Change (% chg)

$-0.13 (-0.82%)
Prev Close
$15.83
Open
$16.02
Day's High
$16.37
Day's Low
$15.49
Volume
165,669
Avg. Vol
197,224
52-wk High
$24.30
52-wk Low
$11.48

Chart for

About

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The... (more)

Overall

Beta: 2.94
Market Cap(Mil.): $723.85
Shares Outstanding(Mil.): 39.45
Dividend: --
Yield (%): --

Financials

  CARA.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.18 -- --
ROI: -30.81 0.60 13.80
ROE: -33.49 -2.18 15.29

Earnings vs. Estimates